Species | Potential target | Raw | Global | Species |
---|---|---|---|---|
Echinococcus multilocularis | dna polymerase kappa | 0.0061 | 0.2082 | 0.2032 |
Echinococcus multilocularis | geminin | 0.0164 | 1 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0042 | 0.0623 | 0.0997 |
Loa Loa (eye worm) | hypothetical protein | 0.0115 | 0.6242 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0164 | 1 | 1 |
Loa Loa (eye worm) | ImpB/MucB/SamB family protein | 0.0061 | 0.2082 | 0.3267 |
Echinococcus granulosus | tar DNA binding protein | 0.0066 | 0.2469 | 0.2421 |
Loa Loa (eye worm) | hypothetical protein | 0.0066 | 0.2493 | 0.3932 |
Toxoplasma gondii | ATP-dependent Clp endopeptidase, proteolytic subunit ClpP domain-containing protein | 0.0081 | 0.3662 | 1 |
Trichomonas vaginalis | rotamase, putative | 0.0035 | 0.0063 | 0.0304 |
Trichomonas vaginalis | conserved hypothetical protein | 0.0035 | 0.0063 | 0.0304 |
Brugia malayi | Calcitonin receptor-like protein seb-1 | 0.0097 | 0.4859 | 0.7762 |
Schistosoma mansoni | DNA polymerase eta | 0.0115 | 0.6242 | 0.6218 |
Schistosoma mansoni | tar DNA-binding protein | 0.0066 | 0.2469 | 0.2421 |
Brugia malayi | RNA binding protein | 0.0066 | 0.2469 | 0.3893 |
Trypanosoma brucei | unspecified product | 0.0042 | 0.0623 | 0.0997 |
Echinococcus multilocularis | peptidase Clp (S14 family) | 0.0053 | 0.1498 | 0.1444 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0061 | 0.2082 | 0.3335 |
Loa Loa (eye worm) | hypothetical protein | 0.0097 | 0.4859 | 0.7762 |
Schistosoma mansoni | tar DNA-binding protein | 0.0066 | 0.2469 | 0.2421 |
Chlamydia trachomatis | ATP-dependent Clp protease proteolytic subunit | 0.0081 | 0.3662 | 0.5 |
Mycobacterium ulcerans | ATP-dependent Clp protease proteolytic subunit | 0.0081 | 0.3662 | 1 |
Wolbachia endosymbiont of Brugia malayi | ATP-dependent Clp protease proteolytic subunit | 0.0081 | 0.3662 | 0.5 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.0073 | 0.2999 | 0.4805 |
Toxoplasma gondii | ATP-dependent Clp endopeptidase, proteolytic subunit ClpP domain-containing protein | 0.0081 | 0.3662 | 1 |
Echinococcus multilocularis | terminal deoxycytidyl transferase rev1 | 0.0061 | 0.2082 | 0.2032 |
Schistosoma mansoni | rab geranylgeranyl transferase alpha subunit | 0.0061 | 0.2082 | 0.2032 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0061 | 0.2082 | 0.3335 |
Trypanosoma brucei | unspecified product | 0.0061 | 0.2082 | 0.3335 |
Echinococcus multilocularis | ATP dependent Clp protease proteolytic subunit | 0.0081 | 0.3662 | 0.3622 |
Plasmodium vivax | ATP-dependent Clp protease proteolytic subunit, putative | 0.0081 | 0.3662 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0061 | 0.2082 | 0.3335 |
Treponema pallidum | ATP-dependent Clp protease proteolytic subunit | 0.0081 | 0.3662 | 0.5 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0042 | 0.0623 | 0.0997 |
Plasmodium falciparum | ATP-dependent Clp protease proteolytic subunit | 0.0081 | 0.3662 | 0.5 |
Schistosoma mansoni | hypothetical protein | 0.0164 | 1 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0061 | 0.2082 | 0.3335 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0061 | 0.2082 | 0.3335 |
Trypanosoma brucei | DNA polymerase eta, putative | 0.0115 | 0.6242 | 1 |
Schistosoma mansoni | hypothetical protein | 0.0066 | 0.2493 | 0.2445 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0042 | 0.0623 | 0.0997 |
Trichomonas vaginalis | DNA polymerase eta, putative | 0.0061 | 0.2082 | 1 |
Schistosoma mansoni | peptidase Clp (S14 family) | 0.0081 | 0.3662 | 0.3622 |
Echinococcus granulosus | peptidase Clp S14 family | 0.0053 | 0.1498 | 0.1444 |
Schistosoma mansoni | tar DNA-binding protein | 0.0066 | 0.2469 | 0.2421 |
Mycobacterium tuberculosis | Possible DNA-damage-inducible protein P DinP (DNA polymerase V) (pol IV 2) (DNA nucleotidyltransferase (DNA-directed)) | 0.0061 | 0.2082 | 1 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0061 | 0.2082 | 0.3335 |
Leishmania major | DNA polymerase eta, putative | 0.0073 | 0.2999 | 0.4805 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0061 | 0.2082 | 0.3267 |
Chlamydia trachomatis | ATP-dependent Clp protease proteolytic subunit | 0.0081 | 0.3662 | 0.5 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0061 | 0.2082 | 0.3335 |
Mycobacterium leprae | PROBABLE ATP-DEPENDENT CLP PROTEASE PROTEOLYTIC SUBUNIT 2 CLPP2 (ENDOPEPTIDASE CLP 2) | 0.0081 | 0.3662 | 1 |
Brugia malayi | ImpB/MucB/SamB family protein | 0.0115 | 0.6242 | 1 |
Echinococcus granulosus | terminal deoxycytidyl transferase rev1 | 0.0061 | 0.2082 | 0.2032 |
Trichomonas vaginalis | DNA polymerase IV / kappa, putative | 0.0061 | 0.2082 | 1 |
Schistosoma mansoni | terminal deoxycytidyl transferase | 0.0061 | 0.2082 | 0.2032 |
Entamoeba histolytica | deoxycytidyl transferase, putative | 0.0061 | 0.2082 | 1 |
Leishmania major | DNA polymerase eta, putative | 0.0115 | 0.6242 | 1 |
Echinococcus multilocularis | dna polymerase eta | 0.0115 | 0.6242 | 0.6218 |
Loa Loa (eye worm) | RNA binding protein | 0.0066 | 0.2469 | 0.3893 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0061 | 0.2082 | 0.3335 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0061 | 0.2082 | 0.3335 |
Brugia malayi | Probable ClpP-like protease | 0.0081 | 0.3662 | 0.5825 |
Brugia malayi | latrophilin 2 splice variant baaae | 0.0066 | 0.2493 | 0.3932 |
Toxoplasma gondii | ImpB/MucB/SamB family protein | 0.0073 | 0.2999 | 0.819 |
Echinococcus granulosus | dna polymerase eta | 0.0115 | 0.6242 | 0.6218 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0061 | 0.2082 | 0.3335 |
Schistosoma mansoni | tar DNA-binding protein | 0.0066 | 0.2469 | 0.2421 |
Brugia malayi | RNA recognition motif domain containing protein | 0.0066 | 0.2469 | 0.3893 |
Leishmania major | DNA polymerase kappa, putative,DNA polymerase IV, putative | 0.0061 | 0.2082 | 0.3335 |
Mycobacterium tuberculosis | Conserved hypothetical protein | 0.0061 | 0.2082 | 1 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0061 | 0.2082 | 0.3335 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0061 | 0.2082 | 0.3335 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0061 | 0.2082 | 0.3335 |
Echinococcus granulosus | ATP dependent Clp protease proteolytic subunit | 0.0081 | 0.3662 | 0.3622 |
Loa Loa (eye worm) | pigment dispersing factor receptor c | 0.0097 | 0.4859 | 0.7762 |
Trypanosoma brucei | DNA polymerase IV, putative | 0.0061 | 0.2082 | 0.3335 |
Schistosoma mansoni | tar DNA-binding protein | 0.0066 | 0.2469 | 0.2421 |
Trypanosoma cruzi | DNA polymerase kappa, putative | 0.0061 | 0.2082 | 0.3335 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0061 | 0.2082 | 0.3335 |
Echinococcus multilocularis | tar DNA binding protein | 0.0066 | 0.2469 | 0.2421 |
Loa Loa (eye worm) | TAR-binding protein | 0.0066 | 0.2469 | 0.3893 |
Trypanosoma cruzi | DNA polymerase eta, putative | 0.0115 | 0.6242 | 1 |
Trypanosoma brucei | unspecified product | 0.0042 | 0.0623 | 0.0997 |
Leishmania major | DNA polymerase kappa, putative | 0.0061 | 0.2082 | 0.3335 |
Echinococcus granulosus | dna polymerase kappa | 0.0061 | 0.2082 | 0.2032 |
Mycobacterium ulcerans | ATP-dependent Clp protease proteolytic subunit | 0.0081 | 0.3662 | 1 |
Brugia malayi | Corticotropin releasing factor receptor 2 precursor, putative | 0.0097 | 0.4859 | 0.7762 |
Loa Loa (eye worm) | hypothetical protein | 0.0081 | 0.3662 | 0.5825 |
Brugia malayi | TAR-binding protein | 0.0066 | 0.2469 | 0.3893 |
Giardia lamblia | DINP protein human, muc B family | 0.0061 | 0.2082 | 0.5 |
Loa Loa (eye worm) | RNA recognition domain-containing protein domain-containing protein | 0.0066 | 0.2469 | 0.3893 |
Trypanosoma brucei | DNA polymerase kappa, putative | 0.0061 | 0.2082 | 0.3335 |
Many chemical entities in TDR Targets come from high-throughput screenings with whole cells or tissue samples, and not all assayed compounds have been tested against a single a single target protein, probably because they get ruled out during screening process. Even if these compounds may have not been of interest in the original screening, they may come as interesting leads for other screening assays. Furthermore, we may be able to propose drug-target associations using chemical similarities and network patterns.